These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Conversion of unresectable hepatoma to resectable. Report of a case and review of the literature. Tepetes KN, Tsamandas AC, Felekouras ES, Salakou SG, Karavias DD. Hepatogastroenterology; 2000; 47(34):1105-9. PubMed ID: 11020889 [Abstract] [Full Text] [Related]
36. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. Yoon HM, Kim JH, Kim EJ, Gwon DI, Ko GY, Ko HK. J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438 [Abstract] [Full Text] [Related]
37. [Transcatheter hepatic arterial chemoembolization and thymosin alpha1 in postoperative treatment of hepatocellular carcinoma]. Cheng SQ, Wu MC, Chen H, Shen F, Yang JH, Cong WM, Zhao YX, Wang PJ. Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):305-7. PubMed ID: 15312371 [Abstract] [Full Text] [Related]
38. [Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results]. Vogl TJ, Zangos S, Balzer JO, Nabil M, Rao P, Eichler K, Bechstein WO, Zeuzem S, Abdelkader A. Rofo; 2007 Nov; 179(11):1113-26. PubMed ID: 17948190 [Abstract] [Full Text] [Related]